Interferon-b: first-line therapy in multiple sclerosis

teaser

Per Soelberg Sorensen

↓Article continues below this sponsored advert↓

Explore the latest advances in respiratory care at events delivered by renowned experts from CofE

AboutTickets

↑Advertisement↑

Danish Multiple Sclerosis Centre,

University of Copenhagen and Department of Neurology, Rigshospitalet, Copenhagen, Denmark

Approximately 85% of patients with multiple sclerosis (MS) have a relapsing